1489 related articles for article (PubMed ID: 27277809)
1. Distinct Nrf2 Signaling Mechanisms of Fumaric Acid Esters and Their Role in Neuroprotection against 1-Methyl-4-Phenyl-1,2,3,6-Tetrahydropyridine-Induced Experimental Parkinson's-Like Disease.
Ahuja M; Ammal Kaidery N; Yang L; Calingasan N; Smirnova N; Gaisin A; Gaisina IN; Gazaryan I; Hushpulian DM; Kaddour-Djebbar I; Bollag WB; Morgan JC; Ratan RR; Starkov AA; Beal MF; Thomas B
J Neurosci; 2016 Jun; 36(23):6332-51. PubMed ID: 27277809
[TBL] [Abstract][Full Text] [Related]
2. Dimethyl fumarate attenuates 6-OHDA-induced neurotoxicity in SH-SY5Y cells and in animal model of Parkinson's disease by enhancing Nrf2 activity.
Jing X; Shi H; Zhang C; Ren M; Han M; Wei X; Zhang X; Lou H
Neuroscience; 2015 Feb; 286():131-40. PubMed ID: 25449120
[TBL] [Abstract][Full Text] [Related]
3. Fumaric acid esters exert neuroprotective effects in neuroinflammation via activation of the Nrf2 antioxidant pathway.
Linker RA; Lee DH; Ryan S; van Dam AM; Conrad R; Bista P; Zeng W; Hronowsky X; Buko A; Chollate S; Ellrichmann G; Brück W; Dawson K; Goelz S; Wiese S; Scannevin RH; Lukashev M; Gold R
Brain; 2011 Mar; 134(Pt 3):678-92. PubMed ID: 21354971
[TBL] [Abstract][Full Text] [Related]
4. The Neuroprotective Effect of Dimethyl Fumarate in an MPTP-Mouse Model of Parkinson's Disease: Involvement of Reactive Oxygen Species/Nuclear Factor-κB/Nuclear Transcription Factor Related to NF-E2.
Campolo M; Casili G; Biundo F; Crupi R; Cordaro M; Cuzzocrea S; Esposito E
Antioxid Redox Signal; 2017 Sep; 27(8):453-471. PubMed ID: 28006954
[TBL] [Abstract][Full Text] [Related]
5. Fumarates promote cytoprotection of central nervous system cells against oxidative stress via the nuclear factor (erythroid-derived 2)-like 2 pathway.
Scannevin RH; Chollate S; Jung MY; Shackett M; Patel H; Bista P; Zeng W; Ryan S; Yamamoto M; Lukashev M; Rhodes KJ
J Pharmacol Exp Ther; 2012 Apr; 341(1):274-84. PubMed ID: 22267202
[TBL] [Abstract][Full Text] [Related]
6. Monomethyl fumarate promotes Nrf2-dependent neuroprotection in retinal ischemia-reperfusion.
Cho H; Hartsock MJ; Xu Z; He M; Duh EJ
J Neuroinflammation; 2015 Dec; 12():239. PubMed ID: 26689280
[TBL] [Abstract][Full Text] [Related]
7. Targeting Nrf2-mediated gene transcription by extremely potent synthetic triterpenoids attenuate dopaminergic neurotoxicity in the MPTP mouse model of Parkinson's disease.
Kaidery NA; Banerjee R; Yang L; Smirnova NA; Hushpulian DM; Liby KT; Williams CR; Yamamoto M; Kensler TW; Ratan RR; Sporn MB; Beal MF; Gazaryan IG; Thomas B
Antioxid Redox Signal; 2013 Jan; 18(2):139-57. PubMed ID: 22746536
[TBL] [Abstract][Full Text] [Related]
8. Tanshinone IIA protects dopaminergic neurons against 6-hydroxydopamine-induced neurotoxicity through miR-153/NF-E2-related factor 2/antioxidant response element signaling pathway.
Zhang XS; Ha S; Wang XL; Shi YL; Duan SS; Li ZA
Neuroscience; 2015 Sep; 303():489-502. PubMed ID: 26116522
[TBL] [Abstract][Full Text] [Related]
9. Naringenin protects against 6-OHDA-induced neurotoxicity via activation of the Nrf2/ARE signaling pathway.
Lou H; Jing X; Wei X; Shi H; Ren D; Zhang X
Neuropharmacology; 2014 Apr; 79():380-8. PubMed ID: 24333330
[TBL] [Abstract][Full Text] [Related]
10. Fumaric acid esters promote neuronal survival upon ischemic stress through activation of the Nrf2 but not HIF-1 signaling pathway.
Lin-Holderer J; Li L; Gruneberg D; Marti HH; Kunze R
Neuropharmacology; 2016 Jun; 105():228-240. PubMed ID: 26801077
[TBL] [Abstract][Full Text] [Related]
11. In vivo modulation of the Parkinsonian phenotype by Nrf2.
Burton NC; Kensler TW; Guilarte TR
Neurotoxicology; 2006 Dec; 27(6):1094-100. PubMed ID: 16959318
[TBL] [Abstract][Full Text] [Related]
12. Dimethyl Fumarate and Monomethyl Fumarate Promote Post-Ischemic Recovery in Mice.
Yao Y; Miao W; Liu Z; Han W; Shi K; Shen Y; Li H; Liu Q; Fu Y; Huang D; Shi FD
Transl Stroke Res; 2016 Dec; 7(6):535-547. PubMed ID: 27614618
[TBL] [Abstract][Full Text] [Related]
13. Potential repositioning of exemestane as a neuroprotective agent for Parkinson's disease.
Son HJ; Han SH; Lee JA; Shin EJ; Hwang O
Free Radic Res; 2017 Jun; 51(6):633-645. PubMed ID: 28770670
[TBL] [Abstract][Full Text] [Related]
14. Tanshinone I selectively suppresses pro-inflammatory genes expression in activated microglia and prevents nigrostriatal dopaminergic neurodegeneration in a mouse model of Parkinson's disease.
Wang S; Jing H; Yang H; Liu Z; Guo H; Chai L; Hu L
J Ethnopharmacol; 2015 Apr; 164():247-55. PubMed ID: 25666429
[TBL] [Abstract][Full Text] [Related]
15. Bruceine D elevates Nrf2 activation to restrain Parkinson's disease in mice through suppressing oxidative stress and inflammatory response.
Yang Y; Kong F; Ding Q; Cai Y; Hao Y; Tang B
Biochem Biophys Res Commun; 2020 Jun; 526(4):1013-1020. PubMed ID: 32321640
[TBL] [Abstract][Full Text] [Related]
16. Ginsenoside Rk1 prevents 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced Parkinson's disease via activating silence information regulator 3-mediated Nrf2/HO-1 signaling pathway.
Ren Y; Ye D; Ding Y; Wei N
Hum Exp Toxicol; 2023; 42():9603271231220610. PubMed ID: 38105596
[No Abstract] [Full Text] [Related]
17. Nrf2-ARE signals mediated the anti-oxidative action of electroacupuncture in an MPTP mouse model of Parkinson's disease.
Lv E; Deng J; Yu Y; Wang Y; Gong X; Jia J; Wang X
Free Radic Res; 2015; 49(11):1296-307. PubMed ID: 26118717
[TBL] [Abstract][Full Text] [Related]
18. Bach1 derepression is neuroprotective in a mouse model of Parkinson's disease.
Ahuja M; Ammal Kaidery N; Attucks OC; McDade E; Hushpulian DM; Gaisin A; Gaisina I; Ahn YH; Nikulin S; Poloznikov A; Gazaryan I; Yamamoto M; Matsumoto M; Igarashi K; Sharma SM; Thomas B
Proc Natl Acad Sci U S A; 2021 Nov; 118(45):. PubMed ID: 34737234
[No Abstract] [Full Text] [Related]
19. Nrf2 activator via interference of Nrf2-Keap1 interaction has antioxidant and anti-inflammatory properties in Parkinson's disease animal model.
Kim S; Indu Viswanath AN; Park JH; Lee HE; Park AY; Choi JW; Kim HJ; Londhe AM; Jang BK; Lee J; Hwang H; Lim SM; Pae AN; Park KD
Neuropharmacology; 2020 May; 167():107989. PubMed ID: 32032607
[TBL] [Abstract][Full Text] [Related]
20. Molecular mechanism underlying the cerebral effect of Gly-Pro-Glu tripeptide bound to L-dopa in a Parkinson's animal model.
Minelli A; Conte C; Cacciatore I; Cornacchia C; Pinnen F
Amino Acids; 2012 Sep; 43(3):1359-67. PubMed ID: 22218995
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
